Large-scale testing (Phase 3)Not Yet RecruitingNCT07177118
What this trial is testing
Risankizumab for Fibrostenotic Crohn's Disease Treatment
Who this might be right for
Crohn DiseaseCrohn Disease and Ulcerative Colitis
First Affiliated Hospital of Wenzhou Medical University 260